SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-021902
Filing Date
2021-09-02
Accepted
2021-09-02 17:24:59
Documents
13
Period of Report
2021-09-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 37660
2 ex99-1.htm EX-99.1 10287
  Complete submission text file 0001493152-21-021902.txt   225637

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE vbio-20210902.xsd EX-101.SCH 3024
4 XBRL LABEL FILE vbio-20210902_lab.xml EX-101.LAB 34915
5 XBRL PRESENTATION FILE vbio-20210902_pre.xml EX-101.PRE 22788
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3659
Mailing Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067
Business Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067 530-231-7800
Vitality Biopharma, Inc. (Filer) CIK: 0001438943 (see all company filings)

IRS No.: 753268988 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-53832 | Film No.: 211234226
SIC: 8731 Services-Commercial Physical & Biological Research